Bio-Techne Corp (TECH) compared with its closest peers (RGEN, BIO, RVTY, QTRX, AZTA): P/E 89.1 vs industry 16.0. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Repligen, Bio-Rad Laboratories, Revvity, Azenta, Bruker, Twist Bioscience, Agilent Technologies, Mesa Laboratories and Pacific Biosciences of California share Bio-Techne's sub-industry, biological products makers.
| Company | Market Cap | P/E |
|---|---|---|
| Repligen Corporation (RGEN) | $10.02B | 241.2 |
| Bio-Rad Laboratories, Inc. (BIO) | $10.08B | 45.3 |
| Revvity, Inc. (RVTY) | $16.01B | 67.4 |
| Quanterix Corporation (QTRX) | $144.33M | — |
| Azenta, Inc. (AZTA) | $1.46B | — |
| Bruker Corporation (BRKR) | $9.35B | — |
| Twist Bioscience Corporation (TWST) | $10.40B | — |
| Agilent Technologies, Inc. (A) | $44.11B | 30.6 |
| Mesa Laboratories, Inc. (MLAB) | $729.93M | 152.1 |
| Pacific Biosciences of California, Inc. (PACB) | $425.60M | — |
| Stock P/E | 89.1 |
| Sector P/E (Healthcare) | 21.5 |
| Industry P/E (Pharmaceutical Products) | 16.0 |
| vs Sector | 315.0% |
| vs Industry | 456.2% |
TECH overview · TECH earnings · TECH financials · TECH KPIs · TECH documents · TECH ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.